Nevimune 200mg
Available Dosages
| SKU | 723 |
|---|---|
| Generic For | Viramune |
| Strength | 200mg |
| Active Ingredient | Nevirapine |
Out Of Stock
Nevimune 200mg – Affordable Viramune Alternative for HIV Treatment
Nevimune 200mg is a drug that belongs to a group of medicines called NHRTI, non-nucleoside reverse transcriptase inhibitors. It is an anti-viral agent used to treat Human Immunodeficiency Virus (HIV). The anti-viral agent is also used with other medicines to treat AIDS or Acquired Immunodeficiency Syndrome caused by the HIV infection. Although, Nevirapine does not relieve of the syndrome but can reduce the risk of developing a HIV-related disease like cancer.The active ingredient present in the 200 mg tablets of Nevimune is Nevirapine.
What is Nevimune 200 mg used for?
The drug, Nevimune 200mg used in the treatment of Human Immunodeficiency Virus (HIV). Its administration does not cure the infection but stops the further growth of the infection in body. Nevirapine prevents the spreading of HIV the blood that causes AIDS.
AIDS is a dreadful disease caused by the HIV infection. The condition alters the immune system of a person by making a person more vulnerable to infections. The immune system of a person gets worsens as the disease progresses.
The Human immunodeficiency virus can be transmitted through different ways such as unsafe sexual intercourse, transmission of blood, breastfeeding or during the childbirth.
Nevimune tablets are used to treat HIV. These tablets are available on our website. Buy Nevimune 200 mg online from our website, premiumrxdrugs.com.
How does Nevimune work?
Nevimune decreases the risk of spreading of HIV in the blood. It prevents the growth of the infection in the body of an infected person. However, its administration does not cure the disease; it may reduce the risk of occurring HIV-related sickness like cancer.
How should Nevimune be taken?
Nevimune is present in the form of tablet. The drug is usually taken once daily for the starting two weeks or as recommended.
It is to be taken orally. Swallow the tablet properly with one glass of water.
One can take Nevimune with or without a meal.
The administration of Nevimune control the HIV infection but does not cure it, therefore, you may have to consume the drug for a long time. Do not discontinue the treatment unless your doctor asked to do so.
- Overdose: The overdose of the drug may cause side effects such as swelling of the limbs, fever, sleeping problem, wheezing, cough, shortness of breath and tender bumps.
Missed dose of Nevimune:
If you miss the dose, and it is less than 2-4 hours left for the next dose then leave the missed dose and take the next dose as per the schedule. In case if it is too late, immediately talk to your doctor. Do not double the dose to compensate the missed one
What are Side effects of Nevimune?
The common adverse effects of Nevimune are as follows:
- Tiredness
- Vomiting
- Diarrhea
- Nausea
The serious adverse events of Nevimune are:
- Itching or rash
- Jaundice (yellow fever)
- Fast heartbeat
- Severe pain in the upper stomach
- Dark urine
- Clay-colored stools
- Loss of appetite and
- Deposition of fat in the stomach and upper back area.
You may also experience side effects other than these so do not get alarmed by the above-mentioned side effects. Immediately call your doctor in above conditions.
What medications interact with Nevimune?
Inform your doctor about the following medications:
- Antifungal drugs such as voriconazole or fluconazole
- Immunosuppressive drugs
- Blood thinners
- Seizure drugs
- Maraviroc
- Fentanyl
- Methadone
- Ergot medicines
- Heart or blood pressure drugs
- Antibiotics drugs
Inform your doctor if you are taking any other drug except Nevimune.
When should Nevimune not be used?
- Avoid taking alcohol while taking the drug.
- Inform your doctor if you are allergic to Nevimune.
- Talk to an expert, if you have a background of hepatitis B or C, Kidney, and Liver disorders.
- If you have high CD4 count, immediately tell your doctor.
How should Nevimune be stored?
- Use preventive measure while practicing sex.
- Always tell your doctor to use a fresh syringe.
- Avoid sharing your toothbrushes.
What is Nevimune 200mg used for?
Nevimune 200mg contains nevirapine 200mg — a first-generation non-nucleoside reverse transcriptase inhibitor (NNRTI) used in combination antiretroviral therapy for HIV-1 infection. Nevirapine inhibits HIV reverse transcriptase non-competitively — blocking viral RNA-to-DNA conversion. It is used as the NNRTI component in triple antiretroviral regimens (combined with two NRTIs), and in prevention of mother-to-child HIV transmission (PMTCT) — single-dose nevirapine to mother at labour onset has been widely deployed in resource-limited settings. Nevimune is a generic formulation making nevirapine-based HIV therapy affordable.
Why does nevirapine require a 14-day lead-in period?
Nevirapine is a potent auto-inducer of CYP3A4 — it induces the enzymes responsible for its own metabolism. Without dose escalation, full-dose nevirapine at initiation produces high plasma levels before CYP3A4 is upregulated, causing excessive drug exposure and significantly higher rates of rash and hepatotoxicity. The lead-in: nevirapine 200mg once daily for 14 days, then 200mg twice daily — allows progressive CYP3A4 induction, reducing peak plasma levels during the highest-risk period for rash. Skin rash occurs in 15–20% of patients, typically in the first 6 weeks — the lead-in period reduces severe rash incidence significantly.
How should Nevimune 200mg be dosed for HIV treatment?
Initiate at 200mg once daily for 14 days (lead-in period), then increase to 200mg twice daily for maintenance. Take with or without food. Consistent twice-daily dosing (12 hours apart) maintains adequate trough levels above the nevirapine EC50 for HIV — low trough levels select K103N-like resistance mutations. Combined with two NRTIs (e.g. lamivudine + zidovudine, or lamivudine + tenofovir) for complete triple antiretroviral therapy. Monitor LFTs closely during the first 18 weeks — hepatotoxicity risk is highest in this period. Never restart nevirapine after a severe rash or hepatotoxicity epiSodiume.
What are the CD4 count restrictions for starting Nevimune 200mg?
Nevirapine is contraindicated for HIV treatment initiation in: women with CD4 >250 cells/mm³ and men with CD4 >400 cells/mm³. These CD4 thresholds identify patients at highest risk of severe, potentially fatal hepatotoxicity with nevirapine — an immune-mediated mechanism causing hepatic necrosis is more likely with stronger immune function. This restriction does not apply to single-dose nevirapine for PMTCT. If CD4 count later falls below these thresholds in a patient already stable on nevirapine therapy, it is generally safe to continue. Patients starting treatment at low CD4 counts (advanced HIV disease) have the most favourable risk profile for nevirapine initiation.
What hepatotoxicity risk does Nevimune 200mg carry?
Nevirapine causes clinically significant hepatotoxicity in 4–6% of patients — the highest hepatotoxicity rate among currently used antiretrovirals. Risk is highest during the first 18 weeks of therapy. Two patterns: (1) Asymptomatic transaminase elevation — managed by LFT monitoring and dose reduction or cessation if ALT/AST >5× upper limit of normal; (2) Symptomatic hepatitis — nausea, fatigue, abdominal pain, jaundice — requires immediate cessation. Hypersensitivity hepatitis (with rash — Stevens-Johnson overlap) can be fatal. Do not rechallenge after symptomatic hepatitis. LFT monitoring schedule: baseline, weeks 2, 4, 8, 12, then every 3 months.
What drug interactions affect Nevimune 200mg?
Nevirapine strongly induces CYP3A4 — reducing plasma levels of: protease inhibitors (lopinavir AUC reduced ~50%; rifampicin — both are CYP3A4 inducers, combination causes very low nevirapine levels; hormonal contraceptives (plasma levels reduced 20–29% — use non-hormonal contraception); methadone (withdrawal risk — dose increase needed); rifabutin (nevirapine reduces rifabutin levels; dose adjustment needed). Azole antifungals (ketoconazole, fluconazole) inhibit CYP3A4 — increase nevirapine levels; monitor for toxicity. St John's Wort induces CYP3A4 — reduces nevirapine levels further; avoid combination.
How does Nevimune 200mg compare to efavirenz for HIV treatment?
Nevimune 200mg (nevirapine) and efavirenz are both medicines used to treat HIV infection. They work by blocking an enzyme the HIV virus needs to multiply. Efavirenz is often preferred because it is usually taken once daily and may provide stronger long-term viral control. However, it can cause side effects like dizziness, vivid dreams, or sleep problems. Nevirapine may be suitable for some patients but has a higher risk of liver problems and skin reactions. The best choice depends on overall health, side effects, and treatment response.
Is Nevimune 200mg equivalent to Viramune 200mg?
Yes. Nevimune 200mg and branded Viramune 200mg both contain nevirapine 200mg in bioequivalent formulations. Nevimune is the generic alternative providing the same HIV NNRTI therapy at significantly lower cost — essential for resource-limited HIV treatment programmes globally.
Can I order Nevimune 200mg from PremiumRxDrugs for international delivery?
Yes. PremiumRxDrugs.com ships Nevimune 200mg to the USA, UK, Australia, and many other countries. Our genuine manufacturer-verified antiretrovirals, competitive pricing, and free worldwide shipping on qualifying orders make us a reliable international pharmacy for nevirapine-based HIV treatment.
What side effects and precautions are most important with Nevimune 200mg?
Critical precautions: complete the 14-day lead-in period at once-daily dosing before escalating to twice daily — never skip; monitor LFTs at weeks 2, 4, 8, 12 then 3-monthly; check and respect CD4 thresholds before initiating; use non-hormonal contraception; educate patient about rash and jaundice warning signs. Stop immediately if: severe rash (blistering, mucosal involvement), signs of hepatitis (jaundice, dark urine, right upper quadrant pain, fatigue + raised LFTs), or hypersensitivity reaction. Never restart after severe reactions. Report any rash to physician promptly — distinguish mild self-limiting rash from the dangerous hypersensitivity pattern.
What monitoring schedule is required for Nevimune 200mg therapy?
Mandatory monitoring: LFTs (ALT/AST) at baseline, weeks 2, 4, 8, 12, then every 3 months for 18 weeks total, then 6-monthly — the highest risk period for hepatotoxicity is the first 18 weeks. HIV viral load every 3–6 months (target: <50 copies/mL); CD4 count every 3–6 months; FBC every 3–6 months (for bone marrow effects from NRTI co-medications); genotypic resistance testing at baseline and if viral load >200 copies/mL; pregnancy testing for women of childbearing age (nevirapine is safer in pregnancy than efavirenz but combined PMTCT strategies require specialist planning). Clinical skin assessment at each visit during the first 6 weeks.
Login
Sign Up
Login
Sign Up